P22 THE PROGNOSTIC ROLE OF 1Q ABNORMALITIES IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
Attucci, I., Pilerci, S., Bonifacio, S., Pengue, L., Buzzichelli, A., Messeri, M., Vannucchi, AM, Antonioli, E.
Published in HemaSphere (09.05.2023)
Published in HemaSphere (09.05.2023)
Get full text
Journal Article
P17 CLONAL PLASMA‐CELLS IN STEM CELL APHERESIS AS A PREDICTOR OF PROGRESSION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS ELEGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION
Pilerci, S., Attucci, I., Pengue, L., Peruzzi, B., Caporale, R., Bencini, S., Messeri, M., Buzzichelli, A., Boncompagni, R., Nozzoli, C., Vannucchi, A.M., Antonioli, E.
Published in HemaSphere (09.05.2023)
Published in HemaSphere (09.05.2023)
Get full text
Journal Article
P48 CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED REFRACTORY MULTIPLE MYELOMA: A PROSPECTIVE REAL‐LIFE EXPERIENCE OF THE REGIONAL TUSCAN MYELOMA NETWORK (RTM)
Attucci, I., Antonioli, E., Pilerci, S., Buda, G., Gozzetti, A., Candi, V., Simonetti, F., Del Giudice, ML, Ciofini, S., Staderini, M., Grammatico, S., Buzzichelli, A., Messeri, M., Bocchia, M., Galimberti, S., Vannucchi, AM
Published in HemaSphere (09.05.2023)
Published in HemaSphere (09.05.2023)
Get full text
Journal Article